Poliscio Analytics LLC
  • Home
  • Daily Alerts
  • Insights
    • Our Insights Articles
    • Project 2025
  • FOIAengine
    • Log In
    • About FOIA Engine
    • Trial User Signup
    • User Support
    • How to Use
  • About
    • About PoliScio
    • Leadership
  • Newsroom
  • Contact
Select Page
“The Assassin” Strike Again

“The Assassin” Strike Again

by John A. Jenkins | Jan 31, 2024 | FDA, FOIA, SEC, Short-Selling, Stock Market

FOIAengine:  Short Seller Fahmi Quadir Goes for Another Kill To keep a nickname like “the Assassin,” the killer better not miss. By the time short seller Fahmi Quadir was scheduled to take the stage on January 30 at a big investment conference in Miami Beach, she had...
A Gambit to Allow Covid Vaccine Lawsuits

A Gambit to Allow Covid Vaccine Lawsuits

by Randy E. Miller | Jan 24, 2024 | FDA, FOIA, Law Firms, Litigation, Pharmaceuticals

In FOIAengine, a Law Firm’s Strategy Takes Shape When we tallied the hundreds of thousands of Freedom of Information Act requests filed with the federal government last year, one law firm stood out. According to PoliScio Analytics’ competitive-intelligence database...
Collateral Damage Follows A Medical Leap

Collateral Damage Follows A Medical Leap

by John A. Jenkins | Jan 3, 2024 | FDA, FOIA, Pharmaceuticals

FOIAengine Lines Up the  Players in a Huge Patent Fight When the Food and Drug Administration announced three weeks ago the approval of two milestone treatments for sickle cell disease, the agency hailed the action as “an innovative advancement in the field of gene...
Implant Manufacturer Targeted by Hedge Funds

Implant Manufacturer Targeted by Hedge Funds

by Randy E. Miller | Dec 13, 2023 | FDA, FOIA, Hedge Funds, Pharmaceuticals, Short-Selling, Stock Market

FOIAengine Reveals FOIA Requests About Establishment Labs Food and Drug Administration FOIA records released this month reveal that breast implant manufacturer Establishment Labs (NASDAQ: ESTA), previously targeted by well-known activist short-seller Hindenburg...
Morgan & Morgan Targets Weight Control Drugs

Morgan & Morgan Targets Weight Control Drugs

by Randy E. Miller | Nov 16, 2023 | FDA, FOIA, Law Firms, Litigation, Pharmaceuticals

FOIAengine Reveals Threat of Litigation Personal injury law firm Morgan & Morgan is gearing up for what could be extensive litigation against the makers of popular weight control drugs. On October 12, the Orlando, Florida-based law firm submitted to the Food and...
Will the Feds Classify Marijuana as a “Safe” Drug?

Will the Feds Classify Marijuana as a “Safe” Drug?

by John A. Jenkins | Nov 2, 2023 | FDA, FOIA, Pharmaceuticals

In FOIAengine, Media Requests Seek the Answer When word leaked in late August that the Department of Health and Human Services recommended that marijuana should no longer be considered a dangerous drug, media organizations quickly responded with a flurry of Freedom of...
« Older Entries
Next Entries »
  • Terms of Service
  • Privacy Policy
Copyright 2025 PoliScio Analytics LLC